- Seventure Partners and Picama will reinvest significantly in Polaris
- Cerea Partners is an independent asset manager with €1.3 billion under management
- The firm is headquartered in Paris, France
Cerea Partners has entered negotiations to acquire a majority stake in Polaris, alongside management, current shareholders Seventure Partners and Picama, and French regional investors. No financial details of the transaction were disclosed.
Polaris is a producer of ingredients for the food supplements, nutraceutical and infant nutrition sectors. The firm, based in Quimper, France, has a turnover of €30 million.
Seventure Partners and Picama will reinvest significantly in Polaris, according to a release.
Cerea’s investment in Polaris will support its plans for international development, particularly in North America and Asia, the release added.
“The development of a sustainable Omega 3 offer from microalgae is part of new consumption habits and is at the heart of the Cerea Capital III fund’s investment strategy as well as the firm’s social corporate responsibility approach,” said Antoine Peyronnet, managing partner at Cerea Partners.
Seventure invested in 2009 in Polaris through its FCPI Retails funds, and in 2021, the firm invested via its Health for Life Capital II fund.
Seventure Partners, based in Paris, France, is a venture capital firm. The firm has €950 million net commitments under management as of the end of 2022.
Cerea Partners is an independent asset manager with €1.3 billion under management, mainly raised with institutional investors. The firm is headquartered in Paris, France.